TRCT
EOLS icon

Tower Research Capital (TRC)’s Evolus EOLS Stock Holding History

Tower Research Capital (TRC)’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42K Buy
10,216
+7,481
+274% +$36.2K ﹤0.01% 2901
2025
Q4 		$18.2K Sell
2,735
-369
-12% -$2.5K ﹤0.01% 3170
2025
Q3 		$19.1K Sell
3,104
-4,260
-58% -$33.2K ﹤0.01% 3357
2025
Q2 		$67.8K Buy
7,364
+5,691
+340% +$58.2K ﹤0.01% 2711
2025
Q1 		$20.1K Sell
1,673
-19,823
-92% -$259K ﹤0.01% 2959
2024
Q4 		$237K Buy
21,496
+17,993
+514% +$253K ﹤0.01% 1599
2024
Q3 		$56.7K Sell
3,503
-1,475
-30% -$20.6K ﹤0.01% 2650
2024
Q2 		$54K Buy
4,978
+4,210
+548% +$51.8K ﹤0.01% 3046
2024
Q1 		$10.8K Sell
768
-9,108
-92% -$118K ﹤0.01% 3657
2023
Q4 		$104K Sell
9,876
-1,732
-15% -$15.5K ﹤0.01% 2620
2023
Q3 		$106K Buy
11,608
+10,289
+780% +$92.3K ﹤0.01% 1938
2023
Q2 		$9.59K Buy
1,319
+359
+37% +$3.1K ﹤0.01% 4251
2023
Q1 		$8K Sell
960
-24,370
-96% -$220K ﹤0.01% 4622
2022
Q4 		$191K Buy
25,330
+18,958
+298% +$147K 0.01% 1330
2022
Q3 		$51K Buy
6,372
+5,221
+454% +$55.4K ﹤0.01% 3140
2022
Q2 		$14K Sell
1,151
-3,087
-73% -$36.4K ﹤0.01% 4135
2022
Q1 		$48K Buy
4,238
+1,955
+86% +$16.7K ﹤0.01% 2761
2021
Q4 		$15K Sell
2,283
-14,625
-86% -$100K ﹤0.01% 3981
2021
Q3 		$128K Buy
16,908
+15,605
+1,198% +$161K ﹤0.01% 2189
2021
Q2 		$16K Sell
1,303
-678
-34% -$7.46K ﹤0.01% 4077
2021
Q1 		$26K Sell
1,981
-3,841
-66% -$35.4K ﹤0.01% 3676
2020
Q4 		$20K Sell
5,822
-17,596
-75% -$66.1K ﹤0.01% 3869
2020
Q3 		$92K Buy
23,418
+16,604
+244% +$60.7K ﹤0.01% 3204
2020
Q2 		$36K Buy
+6,814
New +$31.4K ﹤0.01% 3303
2019
Q4 		– Sell
-396
Closed -$6K – 3745
2019
Q3 		$6K Sell
396
-664
-63% -$10.9K ﹤0.01% 3209
2019
Q2 		$15K Buy
1,060
+189
+22% +$3.75K ﹤0.01% 2337
2019
Q1 		$20K Sell
871
-4,858
-85% -$105K ﹤0.01% 2266
2018
Q4 		$68K Buy
+5,729
New +$81.7K ﹤0.01% 1137
2018
Q3 		– Sell
-6,555
Closed -$183K – 3888
2018
Q2 		$183K Buy
6,555
+5,794
+761% +$102K 0.01% 1107
2018
Q1 		$7K Buy
+761
New +$8.71K ﹤0.01% 2592

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s EOLS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Evolus (EOLS) stake by 274% in Q1 2026, buying an estimated $36.2K and bringing the position to 10,216 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #2901.

Tower Research Capital (TRC) first reported a position in EOLS in Q1 2018 and has held it in 30 quarters since. The position peaked at $237K in Q4 2024. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Tower Research Capital (TRC) held 10,216 shares of Evolus worth $42K as of Q1 2026.
  • Tower Research Capital (TRC) bought 7,481 Evolus shares in Q1 2026, an estimated $36.2K.
  • Evolus made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2901 holding.
  • Tower Research Capital (TRC) first reported a position in Evolus in Q1 2018 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Evolus position peaked at $237K in Q4 2024.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.